Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

May 09, 2019

Newsletter Sponsor

Viral Safety Assurance for Monoclonal Antibodies Prevent, Detect, Remove

A viral contamination can shut down a biopharmaceutical plant for months, impacting manufacturing operations, and threatening drug supply. As there is no single solution that works for every process, we rely on the principles of the biosafety triangle ‘prevent, detect, remove’ to evaluate options for mitigating the risk of viral contamination in the upstream process and for maximizing viral clearance in downstream purification.

	Industry News

Sanofi Announces Licensing of Dupixent® in the EU for Severe Asthma with Type 2 Inflammation

Curadev Announces Licensing Agreement with Takeda for Novel STING Agonist

Jubilant Biosys Selects CDD Vault to Communicate Research Data with Customers

AUGS Partners with Prometheus Research on New Mission-Driven Registry Infrastructure

Mispro Announces Opening of Vivarium Research Facility in Farmingdale, NY

St. Luke’s University Health Network Selects Omnicell to Enhance Efficiency, Safety in Medication Management

	Featured Articles

Using Science to Drive Successful Study Strategy in Hematological Malignancies Advances in our understanding of the genetic drivers of cancer and the immune system’s complex response to cancer have led to significant breakthroughs in the treatment of hematological malignancies. ... read more »

An Interview with... Alcami If current trends hold, it is expected that new parenteral products will be increasingly complex, requiring nonstandard manufacturing technologies subjected to higher standards of regulatory scrutiny ... read more »

	Featured Video

Novel ADC Conjugates: Characterization Tools and Formulation/Process Development
Novel ADC Conjugates: Characterization Tools and Formulation/Process Development read more »

Watch Video: Interview with Michele Luche from AMRI at AAPS 2016
AMRI is a trusted partner for global contract research, testing and manufacturing services for the biopharmaceutical industry. Our specialized solutions include Drug Discovery, such as medicinal ... read more »

	Featured Whitepaper

Vcaps Plus Capsules Hypromellose (HPMC) capsules were originally formulated with a secondary gelling agent. This agent can delay dissolution in some circumstances and ... read more »

How Molded Manifold Assemblies Prevent Leaks and Costly Consequences Traditional fluid transfer systems for biopharm and pharmaceutical applications rely on a multitude of complex components to move liquids from one ... read more »

	Events

SMi’s 3rd Annual Pharmaceutical Microbiology West Coast Conference
San Diego, CA – 06/05/2019
SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, Charles River, DuPont, FujiFilm & Microbiologics CHAIRED BY: Ziva Abraham... event details »

Clinical Operations in Oncology Trials East Coast 2019
Cambridge, MA – 07/10/2019
The Clinical Operations in Oncology Trials (CTO) meeting returned to Boston for its 6th year with over 150 attendees from biopharmaceutical, medical ... event details »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA